ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New Drug For Vaginal Yeast Infections Approved by FDA
June 04, 2021A new and expensive anti-fungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it's not needed. -
FDA Approves Brexafemme (ibrexafungerp) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections
June 03, 2021Scynexis, Inc. (NASDAQ: SCYX) today announced that FDA has approved Brexafemme (ibrexafungerp tablets), for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection.
Pharma Sources Insight January 2025
